Beam Therapeutics (BEAM) Other Gross PP&E Adjustments: 2019-2025
Historic Other Gross PP&E Adjustments for Beam Therapeutics (BEAM) over the last 6 years, with Sep 2025 value amounting to $96.2 million.
- Beam Therapeutics' Other Gross PP&E Adjustments rose 33.80% to $96.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $340.9 million, marking a year-over-year increase of 29.67%. This contributed to the annual value of $75.3 million for FY2024, which is 27.95% up from last year.
- According to the latest figures from Q3 2025, Beam Therapeutics' Other Gross PP&E Adjustments is $96.2 million, which was up 8.23% from $88.9 million recorded in Q2 2025.
- Beam Therapeutics' 5-year Other Gross PP&E Adjustments high stood at $111.5 million for Q2 2022, and its period low was -$47.8 million during Q1 2021.
- In the last 3 years, Beam Therapeutics' Other Gross PP&E Adjustments had a median value of $68.1 million in 2024 and averaged $67.0 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first tumbled by 508.20% in 2021, then soared by 635.49% in 2023.
- Over the past 5 years, Beam Therapeutics' Other Gross PP&E Adjustments (Quarterly) stood at -$5.7 million in 2021, then surged by 459.54% to $20.5 million in 2022, then skyrocketed by 186.60% to $58.8 million in 2023, then increased by 27.95% to $75.3 million in 2024, then spiked by 33.80% to $96.2 million in 2025.
- Its Other Gross PP&E Adjustments was $96.2 million in Q3 2025, compared to $88.9 million in Q2 2025 and $80.5 million in Q1 2025.